| 1 |
34580855 | Hydroxychloroquine inhibits proteolytic processing of endogenous TLR7 protein in human primary plasmacytoid dendritic cells. | 2022 Jan |
6 |
| 2 |
30846987 | Effect of in vivo Hydroxychloroquine and ex vivo Anti-BDCA2 mAb Treatment on pDC IFNα Production From Patients Affected With Cutaneous Lupus Erythematosus. | 2019 |
1 |
| 3 |
31082466 | Effects of hydroxychloroquine on the human placenta-Findings from in vitro experimental data and a systematic review. | 2019 Aug |
1 |
| 4 |
26953155 | Interfering with baffled B cells at the lupus tollway: Promises, successes, and failed expectations. | 2016 May |
1 |
| 5 |
24855048 | Hydroxychloroquine: a multifaceted treatment in lupus. | 2014 Jun |
1 |
| 6 |
22513098 | Antagonist-mediated down-regulation of Toll-like receptors increases the prevalence of human papillomavirus infection in systemic lupus erythematosus. | 2012 Apr 18 |
1 |
| 7 |
22734582 | Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus. | 2012 Jun 27 |
7 |
| 8 |
18220957 | TLR7/9 antagonists as therapeutics for immune-mediated inflammatory disorders. | 2007 Dec |
1 |